Financial information

Facts and figures, shareholder's guide & press releases

Events & financial agenda

Sales figures, results announcements and assembly dates.

26 September 2022
Half year results 2022
31 March 2022
Annual results 2021
31 January 2022
Annual sales 2021
23 September 2021
Half year results 2021
12 July 2021
Half year sales 2021
22 June 2021
Annual Shareholders meeting 2021
22 March 2021
Annual financial results 2020
19 January 2021
Annual sales 2020
Shareholders' guide

Listed on Alternext Paris
Eligible PEA PME
Initial listing: 25 April 2014
Number of shares: 15 247 329
ICB Classification (Sector):
4535 Medical Equipment

Identification codes:
Name: THERACLION
ISIN: FR0010120402
LEI: 9695007X7HA7A1GYD29
Ticker: ALTHE
Bloomberg: ALTHE.FP
Reuters: ALTHE.FA

Annual Closure: 31 December

Liquidity contract:
CM-CIC Market Solutions

Analyst coverage:
Farny Meindre CM-CIC Market Solutions
Thibault Voglimacci-Stephanopoli Invest

 

 

Shareholders
Press releases

Newsworthy statements, milestones and announcements.

2 February 2019
Revenu 2018
24 October 2018
Tübingen/Fus
2 October 2018
Progress in Switzerland and Germany
16 March 2015
Publication on Thyroid
12 March 2015
Asia & Nominations
12 February 2015
Publication in JTU
3 April 2014
FDA approval for IDE in USA for Breast Fibroadenoma
12 December 2012
CE Mark breast fibroadenoma
12 December 2012
CE marking approval for Breast Fibroadenoma
Financial reports & presentations

Key economic and financial information
(click here for more reports) 

Other regulatory documentation

Products Instructions For Use (English)

  • SONOVEIN ref. THC903359-B
  • EPack ref. THC903400-A

Password protected – refer to your training materials.

Contact us

Move to what moves you - for profit AND for people.
Get in touch